U.S., Aug. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07782632) titled 'Liver Volume Metrics for Predicting Immunotherapy Prognosis in Unresectable Hepatocellular Carcinoma' on Aug. 20.
Brief Summary: This multicenter retrospective cohort study aims to evaluate the prognostic value of functional liver volume and total liver volume in patients with unresectable hepatocellular carcinoma (HCC) undergoing immunotherapy. The study explores whether baseline liver volume metrics can effectively predict survival outcomes and treatment responses in this patient population to assist in clinical decision-making.
Study Start Date: Jan. 01, 2019
Study Type: OBSERVATIONAL
Condition:
Hepatocellular Carcinoma (HCC)...